Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
638
datasets available to search
ShareScore release 0.9.0
Dataset results
638 results for “Thrombosis”
Prediction of Cerebral Venous Thrombosis with a new clinical score and D-dimer levels
Open the record for dataset details and reuse information.
Data from: Numerical models for assessing the risk of leaflet thrombosis post-transcatheter aortic valve-in-valve implantation
Open the record for dataset details and reuse information.
Direct oral anticoagulants in treatment of cerebral venous thrombosis: systematic review
Open the record for dataset details and reuse information.
Data from: Trends in incidence and epidemiological characteristics of cerebral venous thrombosis in the United States
Open the record for dataset details and reuse information.
Proposal for a clinical and an echocardiographic score for prediction of left atrial thrombosis in atrial fibrillation patients undergoing early electrical cardioversion
<p>Aims: Left atrial thrombosis (LAT) is usually detected by transesophageal echocardi-<br> ography (TEE). The aim of the present study was to identify clinical and echocardio-<br> graphic factors associated with left atrial thrombosis in atrial fibrillation (AF) patients <br> undergoing early electrical cardioversion (ECV) in order to create scores that can <br> predict LAT, in a non-invasive way.<br> Methods: A consecutive cohort of patients with persistent AF scheduled for ECV <br> was evaluated by transthoracic echocardiography and TEE. By a logistic regression <br> model, variables significantly associated with LAT were assessed and introduced in <br> predictive models to develop both a clinical and an echocardiographic prediction <br> score for the presence of LAT.<br> Results: In total, 125 patients [median 71 (range 49-88) years, 60.0% males] were <br> enrolled. Transesophageal echocardiography showed LAT in 35 patients (28%). The <br> clinical variables significantly associated with LAT were previous stroke (OR = 4.17), <br> higher CHA2DS2-VASc score (OR = 1.93), lower estimated glomerular filtration rate <br> (OR = 0.80), and higher brain natriuretic peptide levels (OR = 1.44). Among echocar-<br> diographic parameters, E/e′ ratio was directly associated with LAT (OR = 2.25), while <br> an inverse correlation was detected with left ventricular ejection fraction (OR = 0.43) <br> and total global left atrial strain (OR = 0.59). Two prediction scores (clinical and echo-<br> cardiographic) were developed. The positive predictive values of the clinical and the <br> echocardiographic score were 80% and 100%, respectively, while the negative pre-<br> dictive values were 98% and 94%, respectively. Combined use of the scores reached <br> a positive and negative predictive value of 100%.<br> Conclusions: When providing concordant information the two scores are able to cor-<br> rectly identify patients with or without LAT. An external validation is necessary to <br> demonstrate their usefulness in the clinical practice.</p>
Acute symptomatic seizures in cerebral venous thrombosis
<p>To identify characteristics, predictors, and outcomes of acute symptomatic seizures (ASS) in cerebral venous thrombosis (CVT), we investigated 1,281 consecutive adult patients with CVT included from 12 hospitals within the International CVT Consortium.</p> <p>We defined ASS as any seizure between symptom onset and 7 days after diagnosis of CVT. We stratified ASS into pre-diagnosis and solely post-diagnosis ASS. Status epilepticus (SE) was also analyzed separately. We analyzed predictors for ASS, and association between ASS and clinical outcome (modified Rankin Scale) with multivariable logistic regression.</p> <p>Of 1,281 eligible patients, 441 (34%) had ASS. Baseline predictors for ASS were intracerebral hemorrhage ([ICH], adjusted odds ratio [aOR] 4.1, 95% confidence interval [CI] 3.0–5.5), cerebral edema/infarction without ICH (aOR 2.8, 95% CI 2.0–4.0), cortical vein thrombosis (aOR 2.1, 95%CI 1.5–2.9), superior sagittal sinus thrombosis (aOR 2.0, 95% CI 1.5–2.6), focal neurologic deficit (aOR 1.9, 95% CI 1.4–2.6), sulcal subarachnoid hemorrhage (aOR 1.6, 95% CI 1.1–2.5) and female-specific risk factors (aOR 1.5, 95% CI 1.1–2.1). Ninety-three (7%) patients had solely post-diagnosis ASS, best predicted by cortical vein thrombosis (positive/negative predictive value 22%/92%). Eighty (6%) patients had SE, independently predicted by ICH, focal neurologic deficits and cerebral edema/infarction. Neither ASS nor SE were independently associated with outcome.</p> <p>ASS occurred in 1/3 of patients with CVT and was associated with brain parenchymal lesions and thrombosis of the superficial system. In absence of pre-diagnosis ASS, no subgroup was identified with sufficient risk of post-diagnosis ASS to justify prophylactic antiepileptic drug treatment. We found no association between ASS and outcome.</p>
Microbe-derived uremic solutes enhance thrombosis potential in the host
<p>Microsoft Excel file containing source data for figures included in the manuscript "Microbe-derived uremic solutes enhance thrombosis potential in the host", by Nemet et al., published in mBio.</p>
Clinical Trial to Evaluate the Accuracy of [99mTc] ThromboView in the Detection of Deep Vein Thrombosis
ClinicalTrials.gov study NCT00123734. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Detection of Asymptomatic Venous Thrombosis in Gynecological Patients With Pelvic Masses
ClinicalTrials.gov study NCT03260270. IPD Sharing: Not stated. Countries: 0. Publications: 5.
Prolonged Anticoagulation Therapy on the Prognosis of Patients With Left Ventricular Thrombosis
ClinicalTrials.gov study NCT06209892. IPD Sharing: NO. Countries: 0. Publications: 3.
Effects Contrast on Platelet Activity, Thrombosis and Fibrinolysis in Patients Undergoing Coronary Angiography
ClinicalTrials.gov study NCT01848899. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosis
ClinicalTrials.gov study NCT01999179. IPD Sharing: NO. Countries: 1. Publications: 0.
The Risk Factors of Thrombosis in Complicated Arteriovenous Fistula
ClinicalTrials.gov study NCT05960877. IPD Sharing: Not stated. Countries: 0. Publications: 7.
Anticoagulation for Non-occlusive Portal Vein Thrombosis in Patients With Liver Cirrhosis
ClinicalTrials.gov study NCT02526303. IPD Sharing: Not stated. Countries: 0. Publications: 2.
JETi Lower Extremity Arterial Thrombosis
ClinicalTrials.gov study NCT04370691. IPD Sharing: NO. Countries: 4. Publications: 0.
Is Red Blood Cell Transfusion a Risk Factor for Vascular Pedicle Thrombosis? The Study Case of a Latin American Cohort
ClinicalTrials.gov study NCT04860544. IPD Sharing: NO. Countries: 0. Publications: 7.
Oral Rivaroxaban in Children With Venous Thrombosis
ClinicalTrials.gov study NCT01684423. IPD Sharing: Not stated. Countries: 10. Publications: 0.
Hormones Inflammation and Thrombosis
ClinicalTrials.gov study NCT01875185. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of Rivaroxaban in Acute Non-neoplastic Portal Vein Thrombosis in HCV
ClinicalTrials.gov study NCT03201367. IPD Sharing: UNDECIDED. Countries: 0. Publications: 1.
Comparison of Different Intermittent Pneumatic Compression Devices for Deep Vein Thrombosis
ClinicalTrials.gov study NCT01779648. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.